General Information
Drug ID
DR00005
Drug Name
L-glutamic acid
Synonyms
(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
Drug Type
Small molecular drug
Indication Indigestion [ICD11: DD90] Approved [1]
Schizophrenia [ICD11: 6A20] Approved [1]
Therapeutic Class
Dietary supplement
Structure
3D MOL 2D MOL
Formula
C5H9NO4
Canonical SMILES
C(CC(=O)O)C(C(=O)O)N
InChI
InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1
InChIKey
WHUUTDBJXJRKMK-VKHMYHEASA-N
CAS Number
CAS 56-86-0
Pharmaceutical Properties Molecular Weight 147.13 Topological Polar Surface Area 101
Heavy Atom Count 10 Rotatable Bond Count 4
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 5
XLogP
-3.7
PubChem CID
33032
PubChem SID
10527679 , 11110117 , 11110137 , 11113412 , 11528393 , 11538992 , 14710662 , 14716143 , 14719817 , 14719819 , 15297417 , 16918839 , 17404216 , 17422134 , 17422293 , 24846358 , 24872908 , 24895052 , 24895223 , 24895340 , 24901609 , 24902257 , 26746616 , 26751652 , 3327 , 34674977 , 46391925 , 627126 , 7847075 , 7887923 , 7979423 , 8023666 , 8026291 , 8026293 , 8143737 , 8172949 , 820094 , 820617 , 822192 , 822517 , 822724 , 822932 , 823119 , 825074 , 826975 , 828108 , 841758 , 854467 , 854468 , 854502
ChEBI ID
ChEBI:16015
TTD Drug ID
D00ENY
DT(s) Transporting This Drug AGT1 Transporter Info Sodium-independent aspartate/glutamate transporter 1 Substrate [2]
ARALAR1 Transporter Info Calcium-binding mitochondrial carrier protein Aralar1 Substrate [3]
ARALAR2 Transporter Info Calcium-binding mitochondrial carrier protein Aralar2 Substrate [4]
EAAT1 Transporter Info Excitatory amino acid transporter 1 Substrate [5]
EAAT2 Transporter Info Excitatory amino acid transporter 2 Substrate [6]
EAAT3 Transporter Info Excitatory amino acid transporter 3 Substrate [7]
EAAT4 Transporter Info Excitatory amino acid transporter 4 Substrate [5]
EAAT5 Transporter Info Excitatory amino acid transporter 5 Substrate [5]
GC1 Transporter Info Mitochondrial glutamate carrier 1 Substrate [8]
GC2 Transporter Info Mitochondrial glutamate carrier 2 Substrate [9]
OAT4 Transporter Info Organic anion transporter 4 Substrate [10]
OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [11]
OCTL3 Transporter Info Organic cation transporter-like 3 Substrate [12]
SLC38A10 Transporter Info Putative sodium-coupled neutral amino acid transporter 10 Substrate [13]
SLC38A8 Transporter Info Putative sodium-coupled neutral amino acid transporter 8 Substrate [14]
SLC7A11 Transporter Info Cystine/glutamate transporter Substrate [15]
VGLUT1 Transporter Info Vesicular glutamate transporter 1 Substrate [16]
VGLUT2 Transporter Info Vesicular glutamate transporter 2 Substrate [16]
VGLUT3 Transporter Info Vesicular glutamate transporter 3 Substrate [16]
Drug-Transporter Activity Data
Drug-Transporter Activity Data EAAT2 Transporter Info Km = 21 microM Human embryonic kidney cells (HEK293)-EAAT2 [17]
EAAT2 Transporter Info Km = 21 microM Human embryonic kidney cells (HEK293)-EAAT2 [18]
EAAT3 Transporter Info Km = 9.9 microM Human embryonic kidney cells (HEK293)-EAAT3 [18]
EAAT3 Transporter Info Km = 25 microM Human embryonic kidney cells (HEK293)-EAAT3 [17]
References
1 L-glutamic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1. Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):775-80.
3 Mitochondrial Aspartate/Glutamate Carrier SLC25A12 and Autism Spectrum Disorder: a Meta-Analysis. Mol Neurobiol. 2016 Apr;53(3):1579-1588.
4 Epigenetic upregulation and functional role of the mitochondrial aspartate/glutamate carrier isoform 1 in hepatocellular carcinoma. Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):38-47.
5 The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol Aspects Med. 2013 Apr-Jun;34(2-3):108-20.
6 EAAT2 (GLT-1; slc1a2) glutamate transporters reconstituted in liposomes argues against heteroexchange being substantially faster than net uptake. J Neurosci. 2014 Oct 1;34(40):13472-85.
7 Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest. 2011 Jan;121(1):446-53.
8 Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet. 2005 Feb;76(2):334-9.
9 The ABCs of membrane transporters in health and disease (SLC series): Introduction. Molecular Aspects of Medicine, 2013, 34(2-3):95-107. (GeneName=SLC25A18)
10 The role of the intracellular glutamate gradient in driving organic anion transporter function.
11 The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.60.1.20)
12 SLC22A13 catalyses unidirectional efflux of aspartate and glutamate at the basolateral membrane of type A intercalated cells in the renal collecting duct. Biochem J. 2014 Jan 15;457(2):243-51.
13 The neuronal and astrocytic protein SLC38A10 transports glutamine, glutamate, and aspartate, suggesting a role in neurotransmission. FEBS Open Bio. 2017 Apr 26;7(6):730-746.
14 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia. Mol Genet Genomic Med. 2017 Feb 26;5(3):202-209.
15 The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. J Biol Chem. 2017 Aug 25;292(34):14240-14249.
16 Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev. 2004 Jul;45(3):250-65.
17 Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3. J Med Chem. 2005 Dec 15;48(25):7980-92.
18 Stereoselective chemoenzymatic synthesis of the four stereoisomers of l-2-(2-carboxycyclobutyl)glycine and pharmacological characterization at human excitatory amino acid transporter subtypes 1, 2, and 3. J Med Chem. 2006 Nov 2;49(22):6532-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.